Medicine & Life Science
Market research for medtech, pharma and life science
In medicine, a product is judged by many people at once: the physician who prescribes it, the nurse who administers it, the pharmacist who prepares it, the purchasing department that signs off - and the patient who lives with it. In more than 25 years, CURTH+ROTH has conducted over 100 projects in medicine and life science. Our medtech clients come from the US, Germany, France, Switzerland, Italy and Malaysia. We help you understand where these perspectives meet, where they differ, and what that means for your product, your service or your communication.

Planning to bring a medical device to Germany? We help you understand acceptance, reimbursement and the decision-makers behind them.
The operating room of the future
Which automation makes sense? Which imaging methods, which monitors? And what role could AR glasses or holograms play? For a medical technology manufacturer we explored these questions Germany-wide with interventional radiologists, cardiologists and commercial decision-makers. Because a solution that convinces in the OR also has to convince the people who sign the purchase order.
Stent design: when is a better product worth a higher price?
With cardiac surgeons and interventional cardiologists at university hospitals, specialist clinics and general hospitals, we discussed a new stent design - its advantages and its perceived disadvantages. The key question: would the efficiency gains justify a higher price, or would that be impossible to explain to financial decision-makers and budget owners?
Telemedicine: expertise where it is needed
A telerobotic system lets specialists at a center of excellence support colleagues in less specialized hospitals. For a young medtech company we explored how such a system could fit into the German healthcare system - from acceptance and reimbursement to clinical approval. We spoke with physicians at hub and spoke hospitals and with those who shape the clinical guidelines.
Cochlear implants: from the OR to everyday hearing
We have conducted several studies on cochlear implants - with ENT surgeons, audiologists, users and parents. Topics ranged from easier implantation, ordering systems and training to fitting technology, product selection and the individual adjustment of hearing profiles.
Ventilation systems: insights for an acquisition
Shortly after the COVID-19 pandemic, a company planned to acquire a German manufacturer of ventilation systems. We guided the search step by step: from a long list to a short list to an in-depth evaluation of the remaining candidates and their products, based on conversations with numerous physicians and scientists. A partner firm contributed the financial analysis. The goal: identify the most future-proof products and the company with the best reputation among experts.
Lab technology: from gas chromatographs to lab computers
How do labs decide which gas chromatograph to buy? And how well does a new device integrate into existing hospital information systems? We explored these questions with lab managers and bench scientists. For lab computers, we looked at design, functions and automation together with users and lab managers - with the goal of generating ideas for the next generations.
Diabetes: questioning the words we use
We have worked on many projects on blood glucose monitoring systems, with users and with healthcare professionals. One finding stuck with us: when HCPs in this context speak of "younger patients", they often mean people under 60. A small example of why we always question the terms that are used - by clients, by users and by ourselves.
For a young medtech company developing a new insulin dosing system, we analyzed international market requirements and helped shape the investor pitch.
Drug dosing systems that relieve staff
Hospitals and care homes need affordable dosing systems. Prescribed injection durations cannot always be met because time and staff are short. In an acceptance study we investigated how a new system could relieve staff and improve patient care.
Oncology: safety and sensitive communication
For a biosimilar manufacturer, CURTH+ROTH ran the German part of an international ethnographic study in hospital pharmacies. We identified two error-prone areas: the compounding system and the delivery to the ward. The client made its compounding system safer at low cost and now addresses pharmacists and pharmacy staff more precisely. You will find the full case study below.
Some research calls for particular care. For a medication used in the palliative treatment of terminally ill cancer patients, we spoke with oncologists, tumor boards, relatives and patients themselves. The goal: an appropriate communication platform that respects everyone involved.
How we work
Many stakeholders, one picture - surgeons, physicians, scientists, lab managers, guideline makers, audiologists, nursing staff, pharmacists, budget owners, patients, parents and relatives: we bring their perspectives together.
Medical expertise in our network - professors, cardiologists and sports physicians in our network help keep our medical knowledge up to date.
Question every term - what a word means depends on who uses it. We clarify before we interpret.
Close to real work - interviews, observation and ethnography in the places where products are actually used.
Respect for sensitive topics - conversations with patients, parents and relatives need time, tact and experience.
Let's talk about your challenges
Tell us what you are working on. We will tell you honestly whether and how qualitative research can help.






